Literature DB >> 35672474

Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS.

Serdar Aslan1, Uluhan Eryuruk2, Merve Nur Tasdemir2, Ismet Mirac Cakir2.   

Abstract

PURPOSE: (1) To evaluate the efficacy of functional liver imaging score (FLIS) in predicting liver function on gadoxetic acid-enhanced MRI in patients with chronic liver disease (CLD) or liver cirrhosis (LC) and its relationship with ALBI grade. (2) To assess the intra-reader reliability and interreader agreement of readers with different levels of experience in abdominal imaging of FLIS.
METHODS: We retrospectively included 131 patients (70 men, 61 women; mean ± SD, 53.7 ± 14.6 years) with CLD and LC who underwent GA-enhanced MRI between November 2019 and March 2022. FLIS was assigned as a result of the sum of three hepatobiliary phase (HBP) images features, each scored 0-2: liver parenchymal enhancement, biliary contrast excretion, and portal vein sign. FLIS was calculated using HPB images independently by three radiologists with different experience. In addition, 50 randomly selected patients were reviewed a second time by a reader to assess intra-reader reliability. Patients were divided into the following three groups according to the albumin-bilirubin (ALBI) grade: ALBI grade 1, 2, and 3. We evaluated the correlation between ALBI grade and both FLIS and its parameters using Spearman's rank correlation for each reader. Receiver operating characteristic (ROC) curve analysis was performed to show the optimal cut-off value of FLIS to distinguish between ALBI grades. Intra-reader reliability and inter-reader agreement were evaluated by intraclass correlation coefficient (ICC).
RESULTS: FLIS and three FLIS parameters showed very strong correlation with ALBI grade for each readers (r =  - 0.843 to 0.976, - 0.831 to 0.962, and - 0.819 to 0.902, respectively). ROC curve analysis showed that FLIS ≥ 5 was the optimal cutoff for prediction of ALBI grade 1 for each readers (sensitivity, 83.7% to 95.4%; specificity, 82.6% to 87%; accuracy, 88.6% to 93.6% and area under the curve (AUC), 0.882 to 0.917), and FLIS ≤ 3 was the optimal cutoff for distinguish ALBI grade 3 from other grades for each readers (sensitivity, 100%; specificity, 95.2% to 96%; accuracy, 95.4% to 96.2% and AUC, 0.974 to 0.994). Intra-reader reliability (ICC = 0.95; 95% CI 0.93-0.96) and inter-reader agreement (ICC = 0.85 to 0.90; 95% CI 0.82-0.97) for FLIS were excellent.
CONCLUSION: FLIS showed a very correlation with hepatic function level and can stratify the ALBI grades. This feature has demonstrated the potential of FLIS to be excellent radiological tools for predicting of liver function of CLD and LC patients in clinical practice. Also, the excellent agreement of FLIS among readers with different levels of experience indicates that it can be used with high accuracy and reproducibility regardless of experience.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Chronic liver disease; Functional liver imaging scores; Gadoxetic acid; Liver cirrhosis; Liver function estimation; Magnetic resonance imaging

Mesh:

Substances:

Year:  2022        PMID: 35672474     DOI: 10.1007/s00261-022-03557-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  22 in total

1.  Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.

Authors:  Steven Sourbron; Wieland H Sommer; Maximilian F Reiser; Christoph J Zech
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

2.  Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.

Authors:  N Verloh; M Haimerl; F Zeman; M Schlabeck; A Barreiros; M Loss; A G Schreyer; C Stroszczynski; C Fellner; P Wiggermann
Journal:  Eur Radiol       Date:  2014-02-16       Impact factor: 5.315

3.  Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.

Authors:  Atsushi Hiraoka; Takashi Kumada; Masatoshi Kudo; Masashi Hirooka; Kunihiko Tsuji; Ei Itobayashi; Kazuya Kariyama; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Toshifumi Tada; Hidenori Toyoda; Kazuhiro Nouso; Kouji Joko; Hideki Kawasaki; Yoichi Hiasa; Kojiro Michitaka
Journal:  Liver Cancer       Date:  2017-03-09       Impact factor: 11.740

Review 4.  The burden of liver disease in Europe: a review of available epidemiological data.

Authors:  Martin Blachier; Henri Leleu; Markus Peck-Radosavljevic; Dominique-Charles Valla; Françoise Roudot-Thoraval
Journal:  J Hepatol       Date:  2013-03       Impact factor: 25.083

5.  Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.

Authors:  Akira Yamada; Takeshi Hara; Feng Li; Yasunari Fujinaga; Kazuhiko Ueda; Masumi Kadoya; Kunio Doi
Journal:  Radiology       Date:  2011-06-28       Impact factor: 11.105

6.  Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.

Authors:  Ho Jun Lee; Seung Baek Hong; Nam Kyung Lee; Suk Kim; Hyung Il Seo; Dong Uk Kim; Sung Yong Han; Ki Suk Choo
Journal:  Eur Radiol       Date:  2021-04-21       Impact factor: 5.315

Review 7.  Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.

Authors:  Aijaz Ahmed; Robert J Wong; Stephen A Harrison
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-27       Impact factor: 11.382

Review 8.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

9.  Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Hyo-Jin Kang; Su Joa Ahn; Hyunkyung Yang; Eunju Kim; Tomoyuki Okuaki; Joon Koo Han
Journal:  Radiology       Date:  2018-10-30       Impact factor: 11.105

10.  Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.

Authors:  Andreas Wibmer; Alexander M Prusa; Richard Nolz; Thomas Gruenberger; Martin Schindl; Ahmed Ba-Ssalamah
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.